PGP and leukemia: PDMP, a GCS inhibitor, and tetrandrine, a P-gp antagonist, were both effective in reversing daunorubicin resistance in a model of drug-resistant leukemia (Table 1G), and both agents enhanced daunorubicin accumulation, evidence that GCS inhibitors have an affinity for P-gp [171].